Abstract: The present invention relates to amorphous form of 5-chloro-N4-[2-[(l-meihylcthyl) sulfonyl]phenyl]-N2-[5-methyl-2-(l-methylethoxy)-4-(4-piperidinyl)phenyl]-2,4-pyrimidine diamine compound of formula-1, represented by the following structure.
DESC: As Attached,CLAIMS: As Attached
| # | Name | Date |
|---|---|---|
| 1 | 201641006515-Other Patent Document-250216.pdf | 2016-03-24 |
| 2 | 201641006515-FORM28-250216.pdf | 2016-03-24 |
| 3 | 201641006515-Form 2(Title Page)-250216.pdf | 2016-03-24 |
| 4 | 201641006515-Form 1-250216.pdf | 2016-03-24 |
| 5 | 201641006515 FORM-28.pdf | 2016-08-16 |
| 6 | OTHERS [24-02-2017(online)].pdf | 2017-02-24 |
| 7 | Description(Complete) [24-02-2017(online)].pdf_579.pdf | 2017-02-24 |
| 8 | Description(Complete) [24-02-2017(online)].pdf | 2017-02-24 |
| 9 | Form 5_CS After PS_27-02-2017.pdf | 2017-02-27 |
| 10 | Form 2 Tilte Page_CS After PS_27-02-2017.pdf | 2017-02-27 |
| 11 | Drawing_CS After PS_27-02-2017.pdf | 2017-02-27 |
| 12 | Description Complete_CS After PS_27-02-2017.pdf | 2017-02-27 |
| 13 | Correspondence by Applicant_CS After PS_27-02-2017.pdf | 2017-02-27 |
| 14 | Claims_CS After PS_27-02-2017.pdf | 2017-02-27 |
| 15 | Abstract_CS After PS_27-02-2017.pdf | 2017-02-27 |